Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00164229 · ClinicalTrials.gov registry record · Phase 1

Fetal Alcohol Syndrome: Socio-Cognitive Habilitation

A Phase 1 study of Fetal Alcohol Syndrome, sponsored by Centers for Disease Control and Prevention.

Completed
Registry status
Phase 1
Development phase
100
Enrollment target
1
Study location

NCT00164229 is a Phase 1 study of Fetal Alcohol Syndrome that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 100 participants, below the 291-participant average among 3 other Fetal Alcohol Syndrome trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00164229, a Phase 1 study of Fetal Alcohol Syndrome, has completed, sponsored by Centers for Disease Control and Prevention.

COMPLETED
Registry status
Phase 1
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

Comprehensive evaluation (geneticist, psychologist, social worker, education specialist, others as indicated) to determine individual needs and treatment plan. Referrals for specific services (e.g., OT, counseling, medications, etc) will be to clinicians within the families' own communities. All families will receive evaluation, parent education/advocacy, and learning readiness program. Only the intervention group will receive the math intervention.

Conditions Studied

Interventions

  • BEHAVIORAL math
  • BEHAVIORAL behavior regulation

Study Locations (1)

Georgia

  • Marcus Institute - Atlanta

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2001-10
Est. Completion 2005-01
Phase Phase 1

What the Registry Record Tells You About NCT00164229

The ClinicalTrials.gov registry entry for NCT00164229 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 291-participant average among 3 other Fetal Alcohol Syndrome trials with a reported enrollment target (66% lower). The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Fetal Alcohol Syndrome appearing as the primary indexed condition, and to 2 interventions - of which math is the first listed.

NCT00164229 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT00164229 about?

NCT00164229 is a clinical study titled "Fetal Alcohol Syndrome: Socio-Cognitive Habilitation". Comprehensive evaluation (geneticist, psychologist, social worker, education specialist, others as indicated) to determine individual needs and treatment plan. Referrals for specific services (e.g., OT, counseling, medications, etc) will be to clinicians within the families' own communities. All fam...

What is the current status of trial NCT00164229?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 100 participants. The study started on 2001-10. Estimated completion is 2005-01.

What conditions does trial NCT00164229 study?

This clinical trial studies the following conditions: Fetal Alcohol Syndrome.

What interventions are being tested in trial NCT00164229?

The interventions under investigation include: math (BEHAVIORAL), behavior regulation (BEHAVIORAL).

Who is sponsoring clinical trial NCT00164229?

This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00164229 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fetal Alcohol Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.